{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T20:13:33Z","timestamp":1780085613564,"version":"3.54.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T00:00:00Z","timestamp":1501286400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"LNCCC","award":["LNCCC-D16-2015"],"award-info":[{"award-number":["LNCCC-D16-2015"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1007\/s11255-017-1671-2","type":"journal-article","created":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T02:20:53Z","timestamp":1501294853000},"page":"1723-1730","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Treatment of obesity-associated overactive bladder by the phosphodiesterase type-4 inhibitor roflumilast"],"prefix":"10.1007","volume":"49","author":[{"given":"Honglin","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoning","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yili","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,7,29]]},"reference":[{"issue":"5","key":"1671_CR1","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/nau.22609","volume":"33","author":"MJ Drake","year":"2014","unstructured":"Drake MJ (2014) Do we need a new definition of the overactive bladder syndrome? ICI-RS 2013. Neurourol Urodyn 33(5):622\u2013624","journal-title":"Neurourol Urodyn"},{"issue":"2","key":"1671_CR2","first-page":"786","volume":"350","author":"DM Gulur","year":"2004","unstructured":"Gulur DM, Drake MJ (2004) Management of overactive bladder. Dis Manage Health Outcomes 350(2):786\u2013799","journal-title":"Dis Manage Health Outcomes"},{"issue":"4","key":"1671_CR3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/nau.22429","volume":"33","author":"JG Wen","year":"2014","unstructured":"Wen JG, Li JS, Wang ZM, Huang CX, Shang XP, Su ZQ, Lu YT, Suo ZH, Wang Y, Qin GJ (2014) The prevalence and risk factors of OAB in middle-aged and old people in China. Neurourol Urodyn 33(4):387\u2013391","journal-title":"Neurourol Urodyn"},{"issue":"5","key":"1671_CR4","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1016\/j.juro.2008.01.029","volume":"179","author":"BA Laven","year":"2008","unstructured":"Laven BA, Orsini N, Andersson SO, Johansson JE, Gerber GS, Wolk A (2008) Birth weight, abdominal obesity and the risk of lower urinary tract symptoms in a population based study of Swedish men. J Urol 179(5):1895\u20131896","journal-title":"J Urol"},{"issue":"12","key":"1671_CR5","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1172\/JCI20514","volume":"112","author":"KE Wellen","year":"2003","unstructured":"Wellen KE, Gs H (2003) Obesity-induced inflammatory changes in adipose tissue. J Clin Investig 112(12):1785\u20131788","journal-title":"J Clin Investig"},{"issue":"10","key":"1671_CR6","doi-asserted-by":"publisher","first-page":"6574","DOI":"10.1074\/jbc.M114.617886","volume":"290","author":"S Haldar","year":"2015","unstructured":"Haldar S, Dru C, Choudhury D, Mishra R, Fernandez A, Biondi S, Liu Z, Shimada K, Arditi M, Bhowmick NA (2015) Inflammation and pyroptosis mediate muscle expansion in an interleukin-1beta (IL-1beta)-dependent manner. J Biol Chem 290(10):6574\u20136583. doi:\n                        10.1074\/jbc.M114.617886","journal-title":"J Biol Chem"},{"issue":"1","key":"1671_CR7","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.urology.2005.07.049","volume":"67","author":"K Bouchelouche","year":"2006","unstructured":"Bouchelouche K, Alvarez S, Horn T, Nordling J, Bouchelouche P (2006) Human detrusor smooth muscle cells release interleukin-6, interleukin-8, and RANTES in response to proinflammatory cytokines interleukin-1\u03b2 and tumor necrosis factor-\u03b1. Urology 67(1):214\u2013219","journal-title":"Urology"},{"issue":"15","key":"1671_CR8","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1002\/pros.20659","volume":"67","author":"S Rohrmann","year":"2005","unstructured":"Rohrmann S, Smit E, Giovannucci E, Platz EA (2005) Association between markers of the metabolic syndrome and lower urinary tract symptoms in the Third National Health and Nutrition Examination Survey (NHANES III). Prostate 67(15):1693\u20131698","journal-title":"Prostate"},{"issue":"3","key":"1671_CR9","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1111\/j.1464-410X.2007.07069.x","volume":"100","author":"NU Rahman","year":"2007","unstructured":"Rahman NU, Phonsombat S, Bochinski D, Carrion RE, Nunes L, Lue TF (2007) An animal model to study lower urinary tract symptoms and erectile dysfunction: the hyperlipidaemic rat. BJU Int 100(3):658\u2013663","journal-title":"BJU Int"},{"issue":"11","key":"1671_CR10","doi-asserted-by":"crossref","first-page":"e48507","DOI":"10.1371\/journal.pone.0048507","volume":"7","author":"LO Leiria","year":"2012","unstructured":"Leiria LO, Sollon C, Calixto MC, Lintomen L, M\u00f3nica FZ, Anh\u00ea GF, De NG, Zanesco A, Grant AD, Antunes E (2012) Role of PKC and CaV1.2 in detrusor overactivity in a model of obesity associated with insulin resistance in mice. PLoS ONE 7(11):e48507\u2013e48507","journal-title":"PLoS ONE"},{"issue":"18","key":"1671_CR11","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1517\/14656560903451682","volume":"10","author":"DR Staskin","year":"2009","unstructured":"Staskin DR, Robinson D (2009) Oxybutynin chloride topical gel: a new formulation of an established antimuscarinic therapy for overactive bladder. Expert Opin Pharmacother 10(18):3103\u20133111","journal-title":"Expert Opin Pharmacother"},{"issue":"7","key":"1671_CR12","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.cellsig.2016.01.007","volume":"28","author":"PH Schafer","year":"2016","unstructured":"Schafer PH, Truzzi F, Parton A, Wu L, Kosek J, Zhang LH, Horan G, Saltari A, Quadri M, Lotti R, Marconi A, Pincelli C (2016) Phosphodiesterase 4 in inflammatory diseases: effects of apremilast in psoriatic blood and in dermal myofibroblasts through the PDE4\/CD271 complex. Cell Signal 28(7):753\u2013763. doi:\n                        10.1016\/j.cellsig.2016.01.007","journal-title":"Cell Signal"},{"issue":"5 Suppl","key":"1671_CR13","doi-asserted-by":"crossref","first-page":"192S","DOI":"10.1378\/chest.121.5_suppl.192S","volume":"121","author":"G Sturton","year":"2002","unstructured":"Sturton G, Fitzgerald M (2002) Phosphodiesterase 4 inhibitors for the treatment of COPD. Chest 121(5 Suppl):192S\u2013196S","journal-title":"Chest"},{"issue":"3","key":"1671_CR14","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.eururo.2006.10.023","volume":"51","author":"S Oger","year":"2007","unstructured":"Oger S, Behr-Roussel D, Gorny D, Denys P, Lebret T, Alexandre L, Giuliano F (2007) Relaxation of phasic contractile activity of human detrusor strips by cyclic nucleotide phosphodiesterase type 4 inhibition. Eur Urol 51(3):772\u2013780; discussion 780\u2013781","journal-title":"Eur Urol"},{"issue":"8","key":"1671_CR15","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1038\/sj.bjp.0701328","volume":"121","author":"PA Longhurst","year":"1997","unstructured":"Longhurst PA, Briscoe JA, Rosenberg DJ, Leggett RE (1997) The role of cyclic nucleotides in guinea-pig bladder contractility. Br J Pharmacol 121(8):1665\u20131672","journal-title":"Br J Pharmacol"},{"issue":"1","key":"1671_CR16","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1124\/jpet.113.210708","volume":"349","author":"W Xin","year":"2014","unstructured":"Xin W, Li N, Cheng Q, Petkov GV (2014) BK channel-mediated relaxation of urinary bladder smooth muscle: a novel paradigm for phosphodiesterase type 4 regulation of bladder function. J Pharmacol Exp Ther 349(1):56","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"1671_CR17","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1471-4159.2003.02217.x","volume":"88","author":"MJ Hansen","year":"2004","unstructured":"Hansen MJ, Jovanovska V, Morris MJ (2004) Adaptive responses in hypothalamic neuropeptide Y in the face of prolonged high-fat feeding in the rat. J Neurochem 88(4):909\u2013916","journal-title":"J Neurochem"},{"issue":"8","key":"1671_CR18","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1111\/iju.12428","volume":"21","author":"EW Fan","year":"2014","unstructured":"Fan EW, Chen LJ, Cheng JT, Tong YC (2014) Changes of urinary bladder contractility in high-fat diet-fed mice: the role of tumor necrosis factor-alpha. Int J Urol 21(8):831\u2013835. doi:\n                        10.1111\/iju.12428","journal-title":"Int J Urol"},{"issue":"1","key":"1671_CR19","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1007\/s11255-016-1455-0","volume":"49","author":"N Li","year":"2016","unstructured":"Li N, He X, Li Z, Liu Y, Wang P (2016) Partial bladder outlet obstruction is associated with decreased expression and function of the small-conductance Ca2+-activated K+ channel in guinea pig detrusor smooth muscle. Int Urol Nephrol 49(1):17\u201326. doi:\n                        10.1007\/s11255-016-1455-0","journal-title":"Int Urol Nephrol"},{"key":"1671_CR20","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-017-1592-0","author":"N Li","year":"2017","unstructured":"Li N, Ding H, He X, Li Z, Liu Y (2017) Expression and function of the small-conductance Ca2+-activated K+ channel is decreased in urinary bladder smooth muscle cells from female guinea pig with partial bladder outlet obstruction. Int Urol Nephrol. doi:\n                        10.1007\/s11255-017-1592-0","journal-title":"Int Urol Nephrol"},{"issue":"4","key":"1671_CR21","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/oby.2003.74","volume":"11","author":"M Bull\u00f3","year":"2003","unstructured":"Bull\u00f3 M, Garc\u00eda-Lorda P, Megias I, Ph.D. JS-SMD (2003) Systemic inflammation, adipose tissue tumor necrosis factor, and leptin expression. Obes Res 11(4):525\u2013531","journal-title":"Obes Res"},{"issue":"8","key":"1671_CR22","doi-asserted-by":"publisher","first-page":"5493","DOI":"10.1074\/jbc.R200029200","volume":"278","author":"M Conti","year":"2003","unstructured":"Conti M, Richter W, Mehats C, Livera G, Park JY, Jin C (2003) Cyclic AMP-specific PDE4 phosphodiesterases as critical components of cyclic AMP signaling. J Biol Chem 278(8):5493\u20135496. doi:\n                        10.1074\/jbc.R200029200","journal-title":"J Biol Chem"},{"issue":"9","key":"1671_CR23","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0006-2952(98)00331-1","volume":"57","author":"DM Essayan","year":"1999","unstructured":"Essayan DM (1999) Cyclic nucleotide phosphodiesterase (PDE) inhibitors and immunomodulation. Biochem Pharmacol 57(9):965\u2013973","journal-title":"Biochem Pharmacol"},{"issue":"71","key":"1671_CR24","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1017\/S0029665112000092","volume":"71","author":"FP Heredia de","year":"2012","unstructured":"de Heredia FP, G\u00f3mezmart\u00ednez S, Marcos A (2012) Obesity, inflammation and the immune system. Proc Nutr Soc 71(71):332\u2013338","journal-title":"Proc Nutr Soc"},{"key":"1671_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2016.10.001","author":"MK Lee","year":"2016","unstructured":"Lee MK, Yvan-Charvet L, Masters SL, Murphy AJ (2016) The modern interleukin-1 superfamily: divergent roles in obesity. Semin Immunol. doi:\n                        10.1016\/j.smim.2016.10.001","journal-title":"Semin Immunol"},{"issue":"5","key":"1671_CR26","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1002\/nau.22558","volume":"33","author":"CH Fry","year":"2014","unstructured":"Fry CH, Sahai A, Vahabi B, Kanai AJ, Birder LA (2014) What is the role for biomarkers for lower urinary tract disorders? ICI-RS 2013. Neurourol Urodyn 33(5):602\u2013605. doi:\n                        10.1002\/nau.22558","journal-title":"Neurourol Urodyn"},{"issue":"3","key":"1671_CR27","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/nau.10066","volume":"21","author":"W Sch\u00e4fer","year":"2002","unstructured":"Sch\u00e4fer W, Abrams P, Liao L, Mattiasson A, Pesce F, Spangberg A, Sterling AM, Zinner NR, Kerrebroeck PV (2002) Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. Neurourol Urodyn 21(3):261\u2013274","journal-title":"Neurourol Urodyn"},{"issue":"168","key":"1671_CR28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0022-5347(05)64369-8","volume":"168","author":"S Seki","year":"2002","unstructured":"Seki S, Sasaki K, Fraser MO, Igawa Y, Nishizawa O, Chancellor MB, de Groat WC, Yoshimura N (2002) Immunoneutralization of nerve growth factor in lumbosacral spinal cord reduces bladder hyperreflexia in spinal cord injured rats. J Urol 168(168):2269\u20132274","journal-title":"J Urol"},{"issue":"3","key":"1671_CR29","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.bbrc.2013.05.002","volume":"435","author":"J Yoon","year":"2013","unstructured":"Yoon J, Ryoo S (2013) Arginase inhibition reduces interleukin-1beta-stimulated vascular smooth muscle cell proliferation by increasing nitric oxide synthase-dependent nitric oxide production. Biochem Biophys Res Commun 435(3):428\u2013433. doi:\n                        10.1016\/j.bbrc.2013.05.002","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"1671_CR30","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1111\/j.1464-410X.2007.07205.x","volume":"100","author":"P Abrams","year":"2007","unstructured":"Abrams P, Andersson KE (2007) Muscarinic receptor antagonists for overactive bladder. BJU Int 100(5):987\u20131006. doi:\n                        10.1111\/j.1464-410X.2007.07205.x","journal-title":"BJU Int"},{"issue":"3 Suppl","key":"1671_CR31","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/bcpt.12577","volume":"119","author":"KE Andersson","year":"2016","unstructured":"Andersson KE (2016) Potential future pharmacological treatment of bladder dysfunction. Basic Clin Pharmacol Toxicol 119(3 Suppl):75\u201385","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"3","key":"1671_CR32","first-page":"123","volume":"24","author":"MC Truss","year":"1996","unstructured":"Truss MC, Uckert S, Stief CG, Forssmann WG, Jonas U (1996) Cyclic nucleotide phosphodiesterase (PDE) isoenzymes in the human detrusor smooth muscle. I. Effect of various PDE inhibitors on smooth muscle tone and cyclic nucleotide levels in vitro. Urolithiasis 24(3):123\u2013128","journal-title":"Urolithiasis"},{"issue":"9691","key":"1671_CR33","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(09)61255-1","volume":"374","author":"PM Calverley","year":"2009","unstructured":"Calverley PM, Rabe KF, Goehring UM, Kristiansen S, Fabbri LM, Martinez FJ (2009) Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet 374(9691):685\u2013694","journal-title":"Lancet"},{"issue":"22","key":"1671_CR34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/S1359-6446(05)03622-6","volume":"10","author":"MD Houslay","year":"2005","unstructured":"Houslay MD, Schafer P, Zhang KY (2005) Phosphodiesterase-4 as a therapeutic target. Drug Discov Today 10(22):1503\u20131519","journal-title":"Drug Discov Today"},{"issue":"1","key":"1671_CR35","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1177\/1753465812466167","volume":"7","author":"Y Oba","year":"2012","unstructured":"Oba Y, Lone NA (2012) Efficacy and safety of roflumilast in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Ther Adv Respir Dis 7(1):13\u201324","journal-title":"Ther Adv Respir Dis"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-017-1671-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-017-1671-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,9,18]],"date-time":"2017-09-18T09:46:00Z","timestamp":1505727960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-017-1671-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,29]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["1671"],"URL":"https:\/\/doi.org\/10.1007\/s11255-017-1671-2","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,29]]}}}